首页|杞菊地黄汤联合苯磺酸左氨氯地平治疗肝肾阴虚型高血压患者的效果

杞菊地黄汤联合苯磺酸左氨氯地平治疗肝肾阴虚型高血压患者的效果

扫码查看
目的:观察杞菊地黄汤联合苯磺酸左氨氯地平治疗肝肾阴虚型高血压患者的效果.方法:选取 2021 年 4 月至 2023 年 4 月该院收治的 60 例肝肾阴虚型高血压患者进行前瞻性研究,按照随机数字表法将其分为研究组和对照组各 30 例.对照组口服苯磺酸左氨氯地平片治疗,研究组在对照组基础上联用杞菊地黄汤治疗,比较两组临床疗效,治疗前后血压、心率、中医证候积分、血管内皮功能指标[内皮素-1(ET-1)、一氧化氮(NO)]水平,以及不良反应发生率.结果:研究组治疗总有效率为93.33%(28/30),高于对照组的73.33%(22/30),差异有统计学意义(P<0.05);治疗后,研究组收缩压、舒张压、心率及中医证候积分均低于对照组,差异有统计学意义(P<0.05);研究组ET-1水平低于对照组,NO水平高于对照组,差异均有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05).结论:杞菊地黄汤联合苯磺酸左氨氯地平治疗肝肾阴虚型高血压患者效果确切,可降低血压、心率和中医证候积分,保护血管内皮功能,效果优于单用苯磺酸左氨氯地平治疗.
Effects of Qiju Dihuang decoction combined with Levamlodipine besylate in treatment of hypertension patients of liver and kidney yin deficiency type
Objective:To observe effects of Qiju Dihuang decoction combined with Levamlodipine besylate in treatment of hypertension patients of liver and kidney yin deficiency type.Methods:A prospective study was conducted on 60 patients with hypertension of liver and kidney yin deficiency type admitted to this hospital from April 2021 to April 2023.They were divided into study group and control group according to the random number table method,30 cases in each group.The control group was treated with Levamlodipine besylate tablets orally,while the study group was treated with Qiju Dihuang decoction on the basis of that of the control group.The clinical efficacy,the levels of blood pressure and heart rate,the TCM syndrome score,the vascular endothelial function index[endothelin-1(ET-1),nitric oxide(NO)]levels before and after the treatment,and the incidence of adverse reactions were compared between the two groups.Results:The total effective rate of the study group was 93.33%(28/30),which was higher than 73.33%(22/30)of the control group,and the difference was statistically significant(P<0.05).After the treatment,the levels of systolic blood pressure,diastolic blood pressure,heart rate and the TCM syndrome scores of the study group were lower than those of the control group,and the differences were statistically significant(P<0.05).After the treatment,the level of ET-1 in the study group was lower than that in the control group,the level of NO was higher than that in the control group,and the differences were statistically significant(P<0.05).However,there was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusions:Qiju Dihuang decoction combined with Levamlodipine besylate is effective in the treatment of the hypertension patients of liver and kidney yin deficiency,which can reduce the levels of blood pressure and heart rate and the TCM syndrome scores,and protect the vascular endothelial function.Moreover,it is superior to simple Levamlodipine besylate treatment.

Qiju Dihuang decoctionLevamlodipineLiver and kidney yin deficiencyHypertensionVascular endothelial function

姚雷杰

展开 >

郑州西区中医院心血管老年病科,河南 郑州 450000

杞菊地黄汤 左氨氯地平 肝肾阴虚 高血压 血管内皮功能

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(16)
  • 12